These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
642 related items for PubMed ID: 27816058
1. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker. Fontecha N, Basaras M, Hernáez S, Andía D, Cisterna R. BMC Cancer; 2016 Nov 05; 16(1):852. PubMed ID: 27816058 [Abstract] [Full Text] [Related]
2. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings. Tezcan S, Ozgur D, Ulger M, Aslan G, Gurses I, Serin MS, Giray BG, Dilek S, Emekdas G. Asian Pac J Cancer Prev; 2014 Nov 05; 15(9):3997-4003. PubMed ID: 24935586 [Abstract] [Full Text] [Related]
3. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia. Persson M, Brismar Wendel S, Ljungblad L, Johansson B, Weiderpass E, Andersson S. Oncol Rep; 2012 Jul 05; 28(1):346-52. PubMed ID: 22484610 [Abstract] [Full Text] [Related]
4. Immunoexpression of HPV 16/18 E6 and E7 oncoproteins in high-grade cervical squamous intraepithelial lesions in HIV-positive women. Rodrigues LC, Speck NM, Focchi GR, Schimidt MA, Marques RM, Ribalta JC. Genet Mol Res; 2016 Feb 19; 15(1):. PubMed ID: 26909984 [Abstract] [Full Text] [Related]
5. Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma. Wu MZ, Li WN, Cha N, Tian LX, Zhang YI, Wu X, Guo KJ, Wu GP. Cell Transplant; 2018 Sep 19; 27(9):1401-1406. PubMed ID: 30056761 [Abstract] [Full Text] [Related]
6. RNA extraction method is crucial for human papillomavirus E6/E7 oncogenes detection. Fontecha N, Nieto MC, Andía D, Cisterna R, Basaras M. Virol J; 2017 Mar 09; 14(1):50. PubMed ID: 28279212 [Abstract] [Full Text] [Related]
7. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA. Perez Castro S, Iñarrea Fernández A, Lamas González MJ, Sarán Diez MT, Cid Lama A, Alvarez Martín MJ, Pato Mosquera M, López-Miragaya I, Estévez N, Torres Piñón J, Oña Navarro M. J Med Virol; 2013 Jun 09; 85(6):1063-8. PubMed ID: 23588733 [Abstract] [Full Text] [Related]
14. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix. Munkhdelger J, Choi Y, Lee D, Kim S, Kim G, Park S, Choi E, Jin H, Jeon BY, Lee H, Park KH. Diagn Microbiol Infect Dis; 2014 Aug 09; 79(4):422-7. PubMed ID: 24856365 [Abstract] [Full Text] [Related]
19. HPV types and E6/E7 mRNA expression in cervical samples from Turkish women with abnormal cytology in Ankara, Turkey. Tüney İ, Altay A, Ergünay K, Önder SÇ, Usubütün A, Salman MC, Bozdayi G, Karabulut E, Badur OS, Yüce K, Pinar A. Turk J Med Sci; 2017 Feb 27; 47(1):194-200. PubMed ID: 28263489 [Abstract] [Full Text] [Related]
20. TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro. Hao Y, Yuan JL, Abudula A, Hasimu A, Kadeer N, Guo X. Asian Pac J Cancer Prev; 2014 Feb 27; 15(14):5867-72. PubMed ID: 25081715 [Abstract] [Full Text] [Related] Page: [Next] [New Search]